Abstract
A coordinated effort to incorporate advances in the understanding of the molecular and genomic variations in common diseases, such as hypertension, into their diagnosis and treatment could transform drug development and medicine.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Classifying diseases by using biological features to identify potential nosological models
Scientific Reports Open Access 26 October 2021
-
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
EPMA Journal Open Access 07 October 2021
-
Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms
Scientific Reports Open Access 05 November 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kola, I. and Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–715 (2004).
Arrowsmith, J. Phase II failures: 2008–2010. Nature Rev. Drug Discov. 10, 328–329 (2011).
Billings, L. K. & Florez, J. C. The genetics of type 2 diabetes: what have we learned from GWAS? Ann. NY Acad. Sci. 1212, 59–77 (2010).
Hyman, S. E. Can neuroscience be integrated into the DSM-V? Nature Rev. Neurosci. 8, 725–732 (2007).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kola, I., Bell, J. A call to reform the taxonomy of human disease. Nat Rev Drug Discov 10, 641–642 (2011). https://doi.org/10.1038/nrd3534
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3534
This article is cited by
-
Classifying diseases by using biological features to identify potential nosological models
Scientific Reports (2021)
-
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
EPMA Journal (2021)
-
Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms
Scientific Reports (2020)
-
Towards a more molecular taxonomy of disease
Journal of Biomedical Semantics (2017)
-
PCAN: phenotype consensus analysis to support disease-gene association
BMC Bioinformatics (2016)